Trial Profile
Effect of Ivabradine on Silent Ambulatory Myocardial Ischemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Coronary artery disease; Ischaemic heart disorders
- Focus Pharmacodynamics
- 02 Sep 2015 Results presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
- 29 Apr 2015 New trial record